Symbiomics, a biotechnology company that develops high-performance biological products for agriculture, today announced the completion of its Series A funding round to scale its operations, accelerate the development of novel products, and expand its commercial partnerships. The round is led by Corteva Agriscience through its investment platform, Corteva Catalyst, launched in mid-2024. In addition to the multinational, the Series A round includes investments from Arar Capital, Cazanga, MOV Investimentos, and The Yield Lab Latam…
